Chapter 1. Abnormal Pap Smear

  1. Errol R. Norwitz MD, PhD Professor Director1,
  2. Michael A. Belfort MD, PhD Professor Director2,3,
  3. George R. Saade MD Professor4 and
  4. Hugh Miller MD5

Published Online: 6 MAY 2010

DOI: 10.1002/9781444314489.ch1

Obstetric Clinical Algorithms: Management and Evidence

Obstetric Clinical Algorithms: Management and Evidence

How to Cite

Norwitz, E. R., Belfort, M. A., Saade, G. R. and Miller, H. (2010) Abnormal Pap Smear, in Obstetric Clinical Algorithms: Management and Evidence, Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314489.ch1

Author Information

  1. 1

    Department of Obstetrics, Gynecology & Reproductive Sciences, Yale-New Haven Hospital, New Haven, CT, USA

  2. 2

    Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA

  3. 3

    Perinatal Research and Fetal Therapy Program, HCA Healthcare, Nashville, TN, USA

  4. 4

    Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, USA

  5. 5

    Department of Obstetrics and Gynecology, University of Arizona, Tucson, AZ, USA

Publication History

  1. Published Online: 6 MAY 2010
  2. Published Print: 23 APR 2010

ISBN Information

Print ISBN: 9781405181112

Online ISBN: 9781444314489

SEARCH

Keywords:

  • preventive health - abnormal pap smear;
  • guidelines for screening frequency - 2004 recommendation by American cancer society;
  • supracervical hysterectomy - continuing guidelines for Pap testing;
  • cervical/vaginal cancer risk - annual screening;
  • endometrial biopsy (EMB) - benign endometrial cells in postmenopausal woman;
  • proceeding to colposcopy - risk factors and reliability of patient follow-up;
  • abnormal glandular cells of undetermined significance (AGUS) - colposcopy with endocervical curettage (ECC);
  • high-grade squamous intraepithelial lesions - progression to invasive cervical cancer